EyePoint Pharmaceuticals Inc. (EYPT) NASDAQ
$12.67 (0.28) (-2.12%)
Market Cap: $673.97M
As of 05/16/24 11:12 AM EDT. Market open.
EyePoint Pharmaceuticals Inc. (EYPT)
NASDAQ
$12.67
(0.28) (-2.12%)
Market Cap: $673.97M
As of 05/16/24 11:12 AM EDT. Market open.
Add to Portfolio
psivida corp., (nasdaq: psdv) (asx: pva) headquartered in watertown, ma, develops tiny, sustained release, drug delivery products designed to deliver drugs at a controlled and steady rate for months or years. psivida is currently focused on treatment of chronic diseases of the back of the eye utilizing its core technology systems, durasert™ and biosilicon™. the injectable, sustained release ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO Compensation (Base)
$551,359
CEO Compensation (Total)
$2.17M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full Time Employees
157
CEO Compensation (Base)
$551,359
CEO Compensation (Total)
$2.17M
URL
Address
.
PRICE CHART FOR EYEPOINT PHARMACEUTICALS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$12.98
Previous Close
$12.94
Days Range
$12.70 - $13.42
52 week range
$5.67 - $30.99
Volume
235,737
Avg. Volume (30 days)
1,776,096
Market Cap
$673.97M
Dividend Yield
-
P/E
-
Shares Outstanding
52,084,375
Open
$12.98
Previous Close
$12.94
Days Range
$12.70 - $13.42
52 week range
$5.67 - $30.99
Volume
235,737
Avg. Volume (30 days)
1,776,096
Market Cap
$673.97M
Dividend Yield
-
P/E
-
Shares Outstanding
52,084,375
FINANCIAL STATEMENTS FOR EYEPOINT PHARMACEUTICALS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR EYEPOINT PHARMACEUTICALS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Cormorant Asset Management, LP | 10% Owner | May 06, 2024 | Buy | $11.86 | 850,000 | 10,081,721 | 8,325,000 | May 08, 2024, 04:23 PM |
| Cormorant Asset Management, LP | 10% Owner | Apr 18, 2024 | Buy | $18.03 | 581,765 | 10,489,446 | 7,475,000 | Apr 22, 2024, 04:00 PM |
| Paggiarino Dario A. | Chief Medical Officer | Mar 30, 2024 | Option Exercise | $20.67 | 25,546 | 528,036 | 77,133 | Apr 02, 2024, 05:27 PM |
| Lurker Nancy | Executive Vice Chair | Feb 09, 2024 | Option Exercise | $28.80 | 14,943 | 430,358 | 165,013 | Feb 13, 2024, 05:40 PM |
| Paggiarino Dario A. | Chief Medical Officer | Feb 09, 2024 | Option Exercise | $28.80 | 5,083 | 146,390 | 44,787 | Feb 13, 2024, 05:39 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Feb 09, 2024 | Option Exercise | $28.80 | 3,656 | 105,293 | 46,617 | Feb 13, 2024, 05:38 PM |
| Elston George | Chief Financial Officer | Feb 09, 2024 | Option Exercise | $28.80 | 3,192 | 91,930 | 45,065 | Feb 13, 2024, 05:38 PM |
| Duker Jay S. | President and CEO | Feb 09, 2024 | Option Exercise | $28.80 | 3,533 | 101,750 | 53,378 | Feb 13, 2024, 05:37 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Feb 02, 2024 | Option Exercise | $11.47 | 209 | 2,397 | 38,171 | Feb 05, 2024, 05:15 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Feb 02, 2024 | Sale | $28.49 | 209 | 5,954 | 37,962 | Feb 05, 2024, 05:15 PM |
| Paggiarino Dario A. | Chief Medical Officer | Jan 26, 2024 | Option Exercise | $13.06 | 49,325 | 644,047 | 85,830 | Jan 30, 2024, 04:53 PM |
| Paggiarino Dario A. | Chief Medical Officer | Jan 26, 2024 | Sale | $25.66 | 49,325 | 1,265,539 | 85,779 | Jan 30, 2024, 04:53 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Jan 26, 2024 | Option Exercise | $6.82 | 26,017 | 177,398 | 63,979 | Jan 29, 2024, 05:54 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Jan 26, 2024 | Sale | $25.38 | 26,017 | 660,370 | 47,566 | Jan 29, 2024, 05:54 PM |
| Paggiarino Dario A. | Chief Medical Officer | Jan 25, 2024 | Option Exercise | $13.01 | 600 | 7,809 | 37,105 | Jan 29, 2024, 05:51 PM |
| Paggiarino Dario A. | Chief Medical Officer | Jan 25, 2024 | Sale | $25.00 | 600 | 15,000 | 36,805 | Jan 29, 2024, 05:51 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Jan 24, 2024 | Option Exercise | $8.04 | 11,300 | 90,822 | 49,262 | Jan 26, 2024, 05:03 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Jan 25, 2024 | Option Exercise | $8.08 | 600 | 4,848 | 38,562 | Jan 26, 2024, 05:03 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Jan 24, 2024 | Sale | $25.01 | 11,300 | 282,621 | 43,562 | Jan 26, 2024, 05:03 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Jan 25, 2024 | Sale | $25.00 | 600 | 15,000 | 38,262 | Jan 26, 2024, 05:03 PM |
| Paggiarino Dario A. | Chief Medical Officer | Jan 24, 2024 | Option Exercise | $13.01 | 11,251 | 146,426 | 47,756 | Jan 25, 2024, 06:26 PM |
| Paggiarino Dario A. | Chief Medical Officer | Jan 23, 2024 | Option Exercise | $13.04 | 5,135 | 66,954 | 41,640 | Jan 25, 2024, 06:26 PM |
| Paggiarino Dario A. | Chief Medical Officer | Jan 24, 2024 | Sale | $25.01 | 11,251 | 281,415 | 42,156 | Jan 25, 2024, 06:26 PM |
| Paggiarino Dario A. | Chief Medical Officer | Jan 23, 2024 | Sale | $25.00 | 5,135 | 128,375 | 39,601 | Jan 25, 2024, 06:26 PM |
| Lurker Nancy | Executive Vice Chair | Jan 24, 2024 | Sale | $24.98 | 29,956 | 748,250 | 135,441 | Jan 25, 2024, 06:24 PM |
| Lurker Nancy | Executive Vice Chair | Jan 23, 2024 | Sale | $24.97 | 5,044 | 125,950 | 165,397 | Jan 25, 2024, 06:24 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Jan 23, 2024 | Option Exercise | $7.54 | 900 | 6,790 | 38,862 | Jan 24, 2024, 04:50 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Jan 22, 2024 | Option Exercise | $10.34 | 34,166 | 353,359 | 72,128 | Jan 24, 2024, 04:50 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Jan 23, 2024 | Sale | $25.00 | 900 | 22,500 | 38,462 | Jan 24, 2024, 04:50 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Jan 22, 2024 | Sale | $22.62 | 34,166 | 772,691 | 66,712 | Jan 24, 2024, 04:50 PM |
| Ocumension Therapeutics | Director | Jan 11, 2024 | Sale | $19.45 | 1,910,500 | 37,159,226 | 100,221 | Jan 16, 2024, 06:55 PM |
| Liu Ye | Director | Jan 11, 2024 | Sale | $19.45 | 1,910,500 | 37,159,226 | 100,221 | Jan 16, 2024, 06:01 PM |
| Cormorant Asset Management, LP | 10% Owner | Jan 11, 2024 | Buy | $19.75 | 750,000 | 14,812,500 | 6,893,235 | Jan 11, 2024, 04:00 PM |
| Cormorant Asset Management, LP | 10% Owner | Jan 09, 2024 | Buy | $21.32 | 105,000 | 2,238,600 | 6,143,235 | Jan 11, 2024, 04:00 PM |
| Paggiarino Dario A. | Chief Medical Officer | Jan 08, 2024 | Option Exercise | $3.26 | 22,913 | 74,696 | 59,418 | Jan 10, 2024, 04:53 PM |
| Paggiarino Dario A. | Chief Medical Officer | Jan 08, 2024 | Sale | $21.13 | 22,913 | 484,124 | 36,505 | Jan 10, 2024, 04:53 PM |
| Paggiarino Dario A. | Chief Medical Officer | Jan 06, 2024 | Option Exercise | $20.40 | 4,487 | 91,535 | 36,505 | Jan 09, 2024, 09:28 PM |
| Lurker Nancy | Executive Vice Chair | Jan 06, 2024 | Option Exercise | $20.40 | 23,043 | 470,077 | 170,441 | Jan 09, 2024, 09:17 PM |
| Pine Michael Craig | Chief Corp Dev.&Strat. Officer | Jan 06, 2024 | Option Exercise | $20.40 | 5,966 | 121,706 | 13,662 | Jan 09, 2024, 09:11 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Jan 06, 2024 | Option Exercise | $20.40 | 4,147 | 84,599 | 37,962 | Jan 09, 2024, 09:09 PM |
| Duker Jay S. | President and CEO | Jan 06, 2024 | Option Exercise | $20.40 | 6,528 | 133,171 | 43,486 | Jan 09, 2024, 09:07 PM |
| Elston George | Chief Financial Officer | Jan 06, 2024 | Option Exercise | $20.40 | 4,911 | 100,184 | 35,308 | Jan 09, 2024, 09:04 PM |
| Paggiarino Dario A. | Chief Medical Officer | Dec 13, 2023 | Option Exercise | $10.13 | 1,458 | 14,770 | 27,165 | Dec 15, 2023, 05:14 PM |
| Paggiarino Dario A. | Chief Medical Officer | Dec 13, 2023 | Sale | $20.00 | 1,458 | 29,160 | 25,707 | Dec 15, 2023, 05:14 PM |
| Cormorant Asset Management, LP | 10% Owner | Dec 08, 2023 | Buy | $17.00 | 588,235 | 9,999,995 | 6,038,235 | Dec 12, 2023, 04:52 PM |
| Pine Michael Craig | Chief Corp Dev.&Strat. Officer | Dec 04, 2023 | Option Exercise | $12.62 | 45,000 | 567,900 | 50,343 | Dec 11, 2023, 04:15 PM |
| Pine Michael Craig | Chief Corp Dev.&Strat. Officer | Dec 04, 2023 | Sale | $21.97 | 46,000 | 1,010,790 | 5,343 | Dec 11, 2023, 04:15 PM |
| Ocumension Therapeutics | Director | Dec 06, 2023 | Sale | $18.41 | 266,242 | 4,901,515 | 2,010,721 | Dec 07, 2023, 09:21 PM |
| Ocumension Therapeutics | Director | Dec 05, 2023 | Sale | $19.91 | 733,758 | 14,609,122 | 2,276,963 | Dec 07, 2023, 09:21 PM |
| Liu Ye | Director | Dec 06, 2023 | Sale | $18.41 | 266,242 | 4,901,515 | 2,010,721 | Dec 07, 2023, 09:03 PM |
| Liu Ye | Director | Dec 05, 2023 | Sale | $19.91 | 733,758 | 14,609,122 | 2,276,963 | Dec 07, 2023, 09:03 PM |
| Pine Michael Craig | Chief Corp Dev.&Strat. Officer | Dec 04, 2023 | Option Exercise | $12.62 | 45,000 | 567,900 | 50,343 | Dec 06, 2023, 05:20 PM |
| Pine Michael Craig | Chief Corp Dev.&Strat. Officer | Dec 04, 2023 | Sale | $22.00 | 45,000 | 990,000 | 5,343 | Dec 06, 2023, 05:20 PM |
| Paggiarino Dario A. | Chief Medical Officer | Dec 04, 2023 | Option Exercise | $10.13 | 30,625 | 310,231 | 56,332 | Dec 06, 2023, 05:19 PM |
| Paggiarino Dario A. | Chief Medical Officer | Dec 04, 2023 | Sale | $22.00 | 30,625 | 673,750 | 25,707 | Dec 06, 2023, 05:19 PM |
| Lurker Nancy | Executive Vice Chair | Dec 04, 2023 | Sale | $20.76 | 20,000 | 415,200 | 170,559 | Dec 06, 2023, 05:18 PM |
| Cormorant Asset Management, LP | 10% Owner | Dec 04, 2023 | Buy | $21.82 | 1,919,057 | 41,874,150 | 5,450,000 | Dec 06, 2023, 04:39 PM |
| EW Healthcare Partners, L.P. | 10% Owner | Sep 01, 2023 | Sale | $9.90 | 20,000 | 197,982 | 3,490,921 | Sep 06, 2023, 07:10 PM |
| EW Healthcare Partners, L.P. | 10% Owner | Sep 01, 2023 | Sale | $9.90 | 20,000 | 197,982 | 3,490,921 | Sep 06, 2023, 05:14 PM |
| EW Healthcare Partners, L.P. | 10% Owner | Aug 31, 2023 | Sale | $10.24 | 78,495 | 804,061 | 3,517,938 | Sep 01, 2023, 04:51 PM |
| EW Healthcare Partners, L.P. | 10% Owner | Aug 30, 2023 | Sale | $10.92 | 60,976 | 666,147 | 3,589,743 | Sep 01, 2023, 04:51 PM |
| EW Healthcare Partners, L.P. | 10% Owner | Aug 29, 2023 | Sale | $10.75 | 87,854 | 944,225 | 3,650,957 | Aug 30, 2023, 05:46 PM |
| EW Healthcare Partners, L.P. | 10% Owner | Aug 28, 2023 | Sale | $11.71 | 60,858 | 712,653 | 3,738,246 | Aug 30, 2023, 05:46 PM |
| EW Healthcare Partners, L.P. | 10% Owner | Aug 25, 2023 | Sale | $11.00 | 84,656 | 931,327 | 3,810,835 | Aug 30, 2023, 05:32 PM |
| EW Healthcare Partners, L.P. | 10% Owner | Aug 24, 2023 | Sale | $11.17 | 139,280 | 1,556,155 | 3,935,940 | Aug 30, 2023, 05:32 PM |
| EW Healthcare Partners, L.P. | 10% Owner | Aug 25, 2023 | Sale | $11.00 | 84,656 | 931,479 | 3,853,760 | Aug 28, 2023, 06:32 PM |
| EW Healthcare Partners, L.P. | 10% Owner | Aug 24, 2023 | Sale | $14.62 | 139,280 | 2,036,093 | 3,883,760 | Aug 28, 2023, 06:32 PM |
| EW Healthcare Partners, L.P. | 10% Owner | Aug 23, 2023 | Sale | $13.05 | 121,103 | 1,580,915 | 4,023,040 | Aug 24, 2023, 05:30 PM |
| EW Healthcare Partners, L.P. | 10% Owner | Aug 22, 2023 | Sale | $14.62 | 46,778 | 683,834 | 4,144,143 | Aug 24, 2023, 05:30 PM |
| Liu Ye | Director | May 30, 2023 | Sale | $6.00 | 1 | 6 | 3,010,721 | May 31, 2023, 05:22 PM |
| Paggiarino Dario A. | Chief Medical Officer | Feb 09, 2023 | Option Exercise | $4.17 | 3,744 | 15,612 | 27,429 | Feb 13, 2023, 05:07 PM |
| Duker Jay S. | President and COO | Feb 09, 2023 | Option Exercise | $4.17 | 4,148 | 17,297 | 30,943 | Feb 13, 2023, 05:03 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Feb 09, 2023 | Option Exercise | $4.17 | 2,956 | 12,327 | 26,606 | Feb 13, 2023, 05:02 PM |
| Duker Jay S. | Chief Operating Officer | Nov 01, 2022 | Option Exercise | $5.42 | 4,479 | 24,276 | 21,402 | Nov 03, 2022, 08:38 AM |
| Pine Michael Craig | Chief Corp Dev.&Strat. Officer | Mar 14, 2022 | Buy | $12.21 | 1,000 | 12,210 | 1,000 | Mar 15, 2022, 04:21 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Feb 28, 2022 | Option Exercise | $9.95 | 1,130 | 11,243 | 15,599 | Mar 02, 2022, 06:22 PM |
| Paggiarino Dario A. | Chief Medical Officer | Feb 28, 2022 | Option Exercise | $9.95 | 1,294 | 12,875 | 18,651 | Mar 02, 2022, 06:21 PM |
| Elston George | Chief Financial Officer | Feb 09, 2022 | Option Exercise | $10.13 | 1,721 | 17,434 | 9,602 | Feb 11, 2022, 04:41 PM |
| Paggiarino Dario A. | Chief Medical Officer | Feb 09, 2022 | Option Exercise | $10.13 | 1,721 | 17,434 | 15,840 | Feb 11, 2022, 04:39 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Feb 09, 2022 | Option Exercise | $10.13 | 1,473 | 14,921 | 12,624 | Feb 11, 2022, 04:39 PM |
| Lurker Nancy | President & CEO | Nov 15, 2021 | Sale | $20.15 | 10,000 | 201,480 | 103,546 | Nov 17, 2021, 05:03 PM |
| Paggiarino Dario A. | Chief Medical Officer | Feb 28, 2021 | Option Exercise | $10.81 | 1,423 | 15,383 | 11,592 | Mar 02, 2021, 07:26 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Feb 28, 2021 | Option Exercise | $10.81 | 1,702 | 18,399 | 7,380 | Mar 02, 2021, 07:25 PM |
| Elston George | Chief Financial Officer | Sep 04, 2020 | Buy | $0.48 | 10,000 | 4,800 | 40,000 | Sep 09, 2020, 09:16 AM |
| Elston George | Chief Financial Officer | Aug 24, 2020 | Buy | $0.61 | 10,000 | 6,112 | 30,000 | Aug 26, 2020, 09:21 AM |
| Jones David Scott | SVP & Chief Commercial Officer | Jun 30, 2020 | Option Exercise | $0.76 | 14,060 | 10,643 | 26,990 | Jul 02, 2020, 06:15 PM |
| Paggiarino Dario A. | Chief Medical Officer | Jun 30, 2020 | Option Exercise | $0.76 | 12,049 | 9,121 | 89,144 | Jul 02, 2020, 06:14 PM |
| Paggiarino Dario A. | Chief Medical Officer | Jun 27, 2020 | Option Exercise | $0.79 | 2,936 | 2,317 | 60,143 | Jun 30, 2020, 07:52 PM |
| Paggiarino Dario A. | Chief Medical Officer | Jun 14, 2020 | Option Exercise | $0.83 | 4,168 | 3,441 | 53,079 | Jun 16, 2020, 05:00 PM |
| Elston George | Chief Financial Officer | Mar 12, 2020 | Buy | $0.96 | 10,000 | 9,600 | 20,000 | Mar 13, 2020, 08:41 AM |
| Lurker Nancy | President & CEO | Mar 10, 2020 | Buy | $1.06 | 98,000 | 104,027 | 574,800 | Mar 11, 2020, 08:40 AM |
| Elston George | Chief Financial Officer | Nov 15, 2019 | Buy | $1.43 | 10,000 | 14,290 | 10,000 | Nov 18, 2019, 08:42 AM |
| Lurker Nancy | President & CEO | Oct 12, 2019 | Option Exercise | $2.11 | 10,745 | 22,618 | 314,455 | Oct 15, 2019, 06:04 PM |
| Paggiarino Dario A. | Chief Medical Officer | Oct 12, 2019 | Option Exercise | $2.11 | 2,450 | 5,157 | 43,047 | Oct 15, 2019, 06:03 PM |
| Mazzo David J | Director | Oct 09, 2019 | Option Exercise | $1.95 | 33,333 | 64,999 | 200,083 | Oct 11, 2019, 06:13 PM |
| Ross Leonard S | See Remarks | Jun 27, 2019 | Option Exercise | $1.65 | 1,961 | 3,236 | 90,044 | Jun 28, 2019, 05:04 PM |
| Paggiarino Dario A. | Chief Medical Officer | Jun 27, 2019 | Option Exercise | $1.65 | 2,940 | 4,851 | 45,497 | Jun 28, 2019, 05:04 PM |
| Ross Leonard S | See Remarks | Jun 14, 2019 | Option Exercise | $1.53 | 2,394 | 3,663 | 85,338 | Jun 17, 2019, 05:41 PM |
| Paggiarino Dario A. | Chief Medical Officer | Jun 14, 2019 | Option Exercise | $1.53 | 4,175 | 6,388 | 38,437 | Jun 17, 2019, 05:40 PM |
| Landis John B. | Director | May 13, 2019 | Buy | $1.74 | 40,000 | 69,600 | 40,000 | May 15, 2019, 04:55 PM |
| Duker Jay S. | Director | Apr 12, 2019 | Option Exercise | $1.77 | 20,000 | 35,400 | 37,500 | Apr 16, 2019, 08:16 AM |
| Duker Jay S. | Director | Apr 01, 2019 | Buy | $1.89 | 5,000 | 9,450 | 17,500 | Apr 03, 2019, 08:25 AM |
| Ross Leonard S | See Remarks | Apr 01, 2019 | Option Exercise | $1.81 | 5,000 | 9,050 | 79,452 | Apr 02, 2019, 08:24 AM |
| Lurker Nancy | President & CEO | Mar 29, 2019 | Buy | $1.76 | 28,500 | 50,246 | 240,200 | Apr 01, 2019, 08:23 AM |
| Mazzo David J | Director | Mar 29, 2019 | Option Exercise | $1.77 | 20,000 | 35,400 | 158,000 | Apr 01, 2019, 08:21 AM |
| Godshall Douglas Evan | Director | Mar 29, 2019 | Buy | $1.75 | 17,000 | 29,784 | 29,500 | Apr 01, 2019, 08:20 AM |
| Paggiarino Dario A. | Chief Medical Officer | Mar 19, 2019 | Option Exercise | $2.47 | 1,188 | 2,934 | 28,412 | Mar 21, 2019, 05:24 PM |
| Ross Leonard S | See Remarks | Mar 19, 2019 | Option Exercise | $2.47 | 1,735 | 4,285 | 74,452 | Mar 21, 2019, 05:22 PM |
| Ross Leonard S | See Remarks | Dec 22, 2018 | Option Exercise | $1.65 | 18,522 | 30,561 | 76,187 | Dec 26, 2018, 04:06 PM |
| ROGERS MICHAEL W | Director | Nov 15, 2018 | Option Exercise | $1.13 | 100,000 | 113,000 | 112,500 | Nov 16, 2018, 04:00 PM |
| Ross Leonard S | See Remarks | Oct 12, 2018 | Option Exercise | $3.23 | 2,945 | 9,512 | 31,817 | Oct 16, 2018, 04:00 PM |
| Paggiarino Dario A. | Chief Medical Officer | Oct 12, 2018 | Option Exercise | $3.23 | 2,455 | 7,930 | 29,600 | Oct 16, 2018, 04:00 PM |
| EW Healthcare Partners, L.P. | 10% Owner | Jun 25, 2018 | Buy | $1.26 | 652,244 | 825,089 | 25,470,390 | Jul 03, 2018, 06:23 PM |
| EW Healthcare Partners, L.P. | 10% Owner | Jun 25, 2018 | Buy | $1.26 | 16,211,822 | 20,507,955 | 25,470,390 | Jul 03, 2018, 06:23 PM |
| Ross Leonard S | See Remarks | Jun 27, 2018 | Option Exercise | $1.86 | 1,904 | 3,541 | 14,762 | Jun 29, 2018, 04:01 PM |
| Paggiarino Dario A. | Chief Medical Officer | Jun 27, 2018 | Option Exercise | $1.86 | 2,945 | 5,478 | 15,388 | Jun 29, 2018, 04:00 PM |
| Mazzo David J | Director | Apr 20, 2018 | Option Exercise | $1.13 | 120,000 | 135,600 | 120,500 | Apr 24, 2018, 04:00 PM |
| EW Healthcare Partners, L.P. | 10% Owner | Mar 28, 2018 | Buy | $1.10 | 332,863 | 366,149 | 8,606,324 | Apr 02, 2018, 01:02 PM |
| EW Healthcare Partners, L.P. | 10% Owner | Mar 28, 2018 | Buy | $1.10 | 8,273,461 | 9,100,807 | 8,606,324 | Apr 02, 2018, 01:02 PM |
| Lurker Nancy | President and CEO | Jun 14, 2017 | Buy | $1.76 | 56,700 | 99,962 | 56,700 | Jun 14, 2017, 04:05 PM |
| Ashton Paul | President & CEO | Mar 18, 2016 | Option Exercise | $1.13 | 10,000 | 11,300 | 450,741 | Mar 22, 2016, 12:24 PM |
| Ross Leonard S | Vice President, Finance | Jan 04, 2016 | Option Exercise | $1.81 | 5,000 | 9,050 | 5,000 | Jan 05, 2016, 05:51 PM |
| Ross Leonard S | Vice President, Finance | Jan 04, 2016 | Sale | $4.70 | 5,000 | 23,500 | 0 | Jan 05, 2016, 05:51 PM |
| Ross Leonard S | Vice President, Finance | Dec 22, 2015 | Option Exercise | $1.81 | 33,950 | 61,449 | 33,950 | Dec 23, 2015, 06:10 PM |
| Ross Leonard S | Vice President, Finance | Dec 22, 2015 | Sale | $5.39 | 33,950 | 182,990 | 0 | Dec 23, 2015, 06:10 PM |
| Ashton Paul | President & CEO | Dec 22, 2015 | Option Exercise | $1.13 | 120,000 | 135,600 | 560,741 | Dec 23, 2015, 06:04 PM |
| Ashton Paul | President & CEO | Dec 22, 2015 | Sale | $5.39 | 120,000 | 646,800 | 440,741 | Dec 23, 2015, 06:04 PM |
| Ross Leonard S | Vice President, Finance | Dec 01, 2015 | Option Exercise | $1.81 | 1,050 | 1,900 | 1,050 | Dec 03, 2015, 03:58 PM |
| Ross Leonard S | Vice President, Finance | Dec 01, 2015 | Sale | $4.06 | 1,050 | 4,263 | 0 | Dec 03, 2015, 03:58 PM |
| Ross Leonard S | Vice President, Finance | Aug 03, 2015 | Option Exercise | $1.81 | 5,000 | 9,050 | 5,000 | Aug 04, 2015, 07:01 PM |
| Ross Leonard S | Vice President, Finance | Aug 03, 2015 | Sale | $4.05 | 5,000 | 20,250 | 0 | Aug 04, 2015, 07:01 PM |
| Ashton Paul | President & CEO | Oct 01, 2014 | Option Exercise | $1.13 | 10,000 | 11,300 | 450,741 | Oct 03, 2014, 10:44 AM |
| Ashton Paul | President & CEO | Oct 01, 2014 | Sale | $4.27 | 10,000 | 42,700 | 440,741 | Oct 03, 2014, 10:44 AM |
| Ashton Paul | President & CEO | Sep 02, 2014 | Option Exercise | $1.13 | 10,000 | 11,300 | 450,741 | Sep 03, 2014, 07:07 PM |
| Ashton Paul | President & CEO | Sep 02, 2014 | Sale | $4.78 | 10,000 | 47,800 | 440,741 | Sep 03, 2014, 07:07 PM |
| Ashton Paul | President & CEO | Aug 01, 2014 | Option Exercise | $1.13 | 10,000 | 11,300 | 450,741 | Aug 04, 2014, 06:17 PM |
| Ashton Paul | President & CEO | Aug 01, 2014 | Sale | $4.37 | 10,000 | 43,700 | 440,741 | Aug 04, 2014, 06:17 PM |
| Ashton Paul | President & CEO | Jul 01, 2014 | Option Exercise | $1.13 | 10,000 | 11,300 | 450,741 | Jul 02, 2014, 05:56 PM |
| Ashton Paul | President & CEO | Jul 01, 2014 | Sale | $4.32 | 10,000 | 43,200 | 440,741 | Jul 02, 2014, 05:56 PM |
| Ashton Paul | President & CEO | Jun 19, 2014 | Option Exercise | $1.13 | 3,069 | 3,468 | 443,810 | Jun 20, 2014, 11:09 AM |
| Ashton Paul | President & CEO | Jun 18, 2014 | Option Exercise | $1.13 | 3,931 | 4,442 | 444,672 | Jun 20, 2014, 11:09 AM |
| Ashton Paul | President & CEO | Jun 18, 2014 | Sale | $4.00 | 3,931 | 15,724 | 440,741 | Jun 20, 2014, 11:09 AM |
| Ashton Paul | President & CEO | Jun 19, 2014 | Sale | $4.00 | 3,069 | 12,276 | 440,741 | Jun 20, 2014, 11:09 AM |
| Freedman Lori | VP Corp. Affairs, GC and Sec | Jun 17, 2014 | Option Exercise | $1.81 | 4,464 | 8,080 | 100,887 | Jun 18, 2014, 05:17 PM |
| Freedman Lori | VP Corp. Affairs, GC and Sec | Jun 16, 2014 | Option Exercise | $1.81 | 3,436 | 6,219 | 99,859 | Jun 18, 2014, 05:17 PM |
| Freedman Lori | VP Corp. Affairs, GC and Sec | Jun 16, 2014 | Sale | $4.01 | 3,436 | 13,778 | 96,423 | Jun 18, 2014, 05:17 PM |
| Freedman Lori | VP Corp. Affairs, GC and Sec | Jun 17, 2014 | Sale | $4.00 | 4,464 | 17,856 | 96,423 | Jun 18, 2014, 05:17 PM |
| Ashton Paul | President & CEO | Jun 16, 2014 | Option Exercise | $1.13 | 3,200 | 3,616 | 443,941 | Jun 18, 2014, 05:11 PM |
| Ashton Paul | President & CEO | Jun 17, 2014 | Option Exercise | $1.13 | 4,500 | 5,085 | 445,241 | Jun 18, 2014, 05:11 PM |
| Ashton Paul | President & CEO | Jun 17, 2014 | Sale | $4.00 | 4,500 | 18,000 | 440,741 | Jun 18, 2014, 05:11 PM |
| Ashton Paul | President & CEO | Jun 16, 2014 | Sale | $4.01 | 3,200 | 12,832 | 440,741 | Jun 18, 2014, 05:11 PM |
| Ashton Paul | President & CEO | Jun 13, 2014 | Option Exercise | $1.13 | 2,200 | 2,486 | 442,941 | Jun 16, 2014, 03:04 PM |
| Ashton Paul | President & CEO | Jun 12, 2014 | Option Exercise | $1.13 | 9,600 | 10,848 | 450,341 | Jun 16, 2014, 03:04 PM |
| Ashton Paul | President & CEO | Jun 13, 2014 | Sale | $4.01 | 2,200 | 8,822 | 440,741 | Jun 16, 2014, 03:04 PM |
| Ashton Paul | President & CEO | Jun 12, 2014 | Sale | $4.02 | 9,600 | 38,592 | 440,741 | Jun 16, 2014, 03:04 PM |
| Freedman Lori | VP Corp. Affairs, GC and Sec | Jun 13, 2014 | Option Exercise | $1.81 | 2,100 | 3,801 | 98,523 | Jun 16, 2014, 02:49 PM |
| Freedman Lori | VP Corp. Affairs, GC and Sec | Jun 12, 2014 | Option Exercise | $1.81 | 9,600 | 17,376 | 106,023 | Jun 16, 2014, 02:49 PM |
| Freedman Lori | VP Corp. Affairs, GC and Sec | Jun 13, 2014 | Sale | $4.01 | 2,100 | 8,421 | 96,423 | Jun 16, 2014, 02:49 PM |
| Freedman Lori | VP Corp. Affairs, GC and Sec | Jun 12, 2014 | Sale | $4.02 | 9,600 | 38,592 | 96,423 | Jun 16, 2014, 02:49 PM |
| Freedman Lori | VP Corp. Affairs, GC and Sec | May 05, 2014 | Option Exercise | $1.81 | 3,500 | 6,335 | 99,923 | May 07, 2014, 07:21 PM |
| Freedman Lori | VP Corp. Affairs, GC and Sec | May 05, 2014 | Sale | $4.01 | 3,500 | 14,035 | 96,423 | May 07, 2014, 07:21 PM |
| Ashton Paul | President & CEO | May 05, 2014 | Option Exercise | $1.13 | 3,500 | 3,955 | 444,241 | May 07, 2014, 07:15 PM |
| Ashton Paul | President & CEO | May 05, 2014 | Sale | $4.01 | 3,500 | 14,035 | 440,741 | May 07, 2014, 07:15 PM |
| Hopper Paul | Director | Oct 01, 2012 | Buy | $1.67 | 10,000 | 16,750 | 10,000 | Oct 09, 2012, 12:08 PM |
| Hopper Paul | Director | Oct 01, 2012 | Buy | $1.62 | 10,000 | 16,150 | 10,000 | Oct 03, 2012, 07:36 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Cormorant Asset Management, LP | 10% Owner | 05/06/2024 | 10,081,721 |
| Cormorant Asset Management, LP | 10% Owner | 04/18/2024 | 10,489,446 |
| Paggiarino Dario A. | Chief Medical Officer | 03/30/2024 | 528,036 |
| Lurker Nancy | Executive Vice Chair | 02/09/2024 | 430,358 |
| Paggiarino Dario A. | Chief Medical Officer | 02/09/2024 | 146,390 |
| Jones David Scott | SVP & Chief Commercial Officer | 02/09/2024 | 105,293 |
| Elston George | Chief Financial Officer | 02/09/2024 | 91,930 |
| Duker Jay S. | President and CEO | 02/09/2024 | 101,750 |
| Jones David Scott | SVP & Chief Commercial Officer | 02/02/2024 | 2,397 |
| Jones David Scott | SVP & Chief Commercial Officer | 02/02/2024 | 5,954 |
| Paggiarino Dario A. | Chief Medical Officer | 01/26/2024 | 644,047 |
| Paggiarino Dario A. | Chief Medical Officer | 01/26/2024 | 1,265,539 |
| Jones David Scott | SVP & Chief Commercial Officer | 01/26/2024 | 177,398 |
| Jones David Scott | SVP & Chief Commercial Officer | 01/26/2024 | 660,370 |
| Paggiarino Dario A. | Chief Medical Officer | 01/25/2024 | 7,809 |
| Paggiarino Dario A. | Chief Medical Officer | 01/25/2024 | 15,000 |
| Jones David Scott | SVP & Chief Commercial Officer | 01/24/2024 | 90,822 |
| Jones David Scott | SVP & Chief Commercial Officer | 01/25/2024 | 4,848 |
| Jones David Scott | SVP & Chief Commercial Officer | 01/24/2024 | 282,621 |
| Jones David Scott | SVP & Chief Commercial Officer | 01/25/2024 | 15,000 |
| Paggiarino Dario A. | Chief Medical Officer | 01/24/2024 | 146,426 |
| Paggiarino Dario A. | Chief Medical Officer | 01/23/2024 | 66,954 |
| Paggiarino Dario A. | Chief Medical Officer | 01/24/2024 | 281,415 |
| Paggiarino Dario A. | Chief Medical Officer | 01/23/2024 | 128,375 |
| Lurker Nancy | Executive Vice Chair | 01/24/2024 | 748,250 |
| Lurker Nancy | Executive Vice Chair | 01/23/2024 | 125,950 |
| Jones David Scott | SVP & Chief Commercial Officer | 01/23/2024 | 6,790 |
| Jones David Scott | SVP & Chief Commercial Officer | 01/22/2024 | 353,359 |
| Jones David Scott | SVP & Chief Commercial Officer | 01/23/2024 | 22,500 |
| Jones David Scott | SVP & Chief Commercial Officer | 01/22/2024 | 772,691 |
| Ocumension Therapeutics | Director | 01/11/2024 | 37,159,226 |
| Liu Ye | Director | 01/11/2024 | 37,159,226 |
| Cormorant Asset Management, LP | 10% Owner | 01/11/2024 | 14,812,500 |
| Cormorant Asset Management, LP | 10% Owner | 01/09/2024 | 2,238,600 |
| Paggiarino Dario A. | Chief Medical Officer | 01/08/2024 | 74,696 |
| Paggiarino Dario A. | Chief Medical Officer | 01/08/2024 | 484,124 |
| Paggiarino Dario A. | Chief Medical Officer | 01/06/2024 | 91,535 |
| Lurker Nancy | Executive Vice Chair | 01/06/2024 | 470,077 |
| Pine Michael Craig | Chief Corp Dev.&Strat. Officer | 01/06/2024 | 121,706 |
| Jones David Scott | SVP & Chief Commercial Officer | 01/06/2024 | 84,599 |
| Duker Jay S. | President and CEO | 01/06/2024 | 133,171 |
| Elston George | Chief Financial Officer | 01/06/2024 | 100,184 |
| Paggiarino Dario A. | Chief Medical Officer | 12/13/2023 | 14,770 |
| Paggiarino Dario A. | Chief Medical Officer | 12/13/2023 | 29,160 |
| Cormorant Asset Management, LP | 10% Owner | 12/08/2023 | 9,999,995 |
| Pine Michael Craig | Chief Corp Dev.&Strat. Officer | 12/04/2023 | 567,900 |
| Pine Michael Craig | Chief Corp Dev.&Strat. Officer | 12/04/2023 | 1,010,790 |
| Ocumension Therapeutics | Director | 12/06/2023 | 4,901,515 |
| Ocumension Therapeutics | Director | 12/05/2023 | 14,609,122 |
| Liu Ye | Director | 12/06/2023 | 4,901,515 |
| Liu Ye | Director | 12/05/2023 | 14,609,122 |
| Pine Michael Craig | Chief Corp Dev.&Strat. Officer | 12/04/2023 | 567,900 |
| Pine Michael Craig | Chief Corp Dev.&Strat. Officer | 12/04/2023 | 990,000 |
| Paggiarino Dario A. | Chief Medical Officer | 12/04/2023 | 310,231 |
| Paggiarino Dario A. | Chief Medical Officer | 12/04/2023 | 673,750 |
| Lurker Nancy | Executive Vice Chair | 12/04/2023 | 415,200 |
| Cormorant Asset Management, LP | 10% Owner | 12/04/2023 | 41,874,150 |
| EW Healthcare Partners, L.P. | 10% Owner | 09/01/2023 | 197,982 |
| EW Healthcare Partners, L.P. | 10% Owner | 09/01/2023 | 197,982 |
| EW Healthcare Partners, L.P. | 10% Owner | 08/31/2023 | 804,061 |
| EW Healthcare Partners, L.P. | 10% Owner | 08/30/2023 | 666,147 |
| EW Healthcare Partners, L.P. | 10% Owner | 08/29/2023 | 944,225 |
| EW Healthcare Partners, L.P. | 10% Owner | 08/28/2023 | 712,653 |
| EW Healthcare Partners, L.P. | 10% Owner | 08/25/2023 | 931,327 |
| EW Healthcare Partners, L.P. | 10% Owner | 08/24/2023 | 1,556,155 |
| EW Healthcare Partners, L.P. | 10% Owner | 08/25/2023 | 931,479 |
| EW Healthcare Partners, L.P. | 10% Owner | 08/24/2023 | 2,036,093 |
| EW Healthcare Partners, L.P. | 10% Owner | 08/23/2023 | 1,580,915 |
| EW Healthcare Partners, L.P. | 10% Owner | 08/22/2023 | 683,834 |
| Liu Ye | Director | 05/30/2023 | 6 |
| Paggiarino Dario A. | Chief Medical Officer | 02/09/2023 | 15,612 |
| Duker Jay S. | President and COO | 02/09/2023 | 17,297 |
| Jones David Scott | SVP & Chief Commercial Officer | 02/09/2023 | 12,327 |
| Duker Jay S. | Chief Operating Officer | 11/01/2022 | 24,276 |
| Pine Michael Craig | Chief Corp Dev.&Strat. Officer | 03/14/2022 | 12,210 |
| Jones David Scott | SVP & Chief Commercial Officer | 02/28/2022 | 11,243 |
| Paggiarino Dario A. | Chief Medical Officer | 02/28/2022 | 12,875 |
| Elston George | Chief Financial Officer | 02/09/2022 | 17,434 |
| Paggiarino Dario A. | Chief Medical Officer | 02/09/2022 | 17,434 |
| Jones David Scott | SVP & Chief Commercial Officer | 02/09/2022 | 14,921 |
| Lurker Nancy | President & CEO | 11/15/2021 | 201,480 |
| Paggiarino Dario A. | Chief Medical Officer | 02/28/2021 | 15,383 |
| Jones David Scott | SVP & Chief Commercial Officer | 02/28/2021 | 18,399 |
| Elston George | Chief Financial Officer | 09/04/2020 | 4,800 |
| Elston George | Chief Financial Officer | 08/24/2020 | 6,112 |
| Jones David Scott | SVP & Chief Commercial Officer | 06/30/2020 | 10,643 |
| Paggiarino Dario A. | Chief Medical Officer | 06/30/2020 | 9,121 |
| Paggiarino Dario A. | Chief Medical Officer | 06/27/2020 | 2,317 |
| Paggiarino Dario A. | Chief Medical Officer | 06/14/2020 | 3,441 |
| Elston George | Chief Financial Officer | 03/12/2020 | 9,600 |
| Lurker Nancy | President & CEO | 03/10/2020 | 104,027 |
| Elston George | Chief Financial Officer | 11/15/2019 | 14,290 |
| Lurker Nancy | President & CEO | 10/12/2019 | 22,618 |
| Paggiarino Dario A. | Chief Medical Officer | 10/12/2019 | 5,157 |
| Mazzo David J | Director | 10/09/2019 | 64,999 |
| Ross Leonard S | See Remarks | 06/27/2019 | 3,236 |
| Paggiarino Dario A. | Chief Medical Officer | 06/27/2019 | 4,851 |
| Ross Leonard S | See Remarks | 06/14/2019 | 3,663 |
| Paggiarino Dario A. | Chief Medical Officer | 06/14/2019 | 6,388 |
| Landis John B. | Director | 05/13/2019 | 69,600 |
| Duker Jay S. | Director | 04/12/2019 | 35,400 |
| Duker Jay S. | Director | 04/01/2019 | 9,450 |
| Ross Leonard S | See Remarks | 04/01/2019 | 9,050 |
| Lurker Nancy | President & CEO | 03/29/2019 | 50,246 |
| Mazzo David J | Director | 03/29/2019 | 35,400 |
| Godshall Douglas Evan | Director | 03/29/2019 | 29,784 |
| Paggiarino Dario A. | Chief Medical Officer | 03/19/2019 | 2,934 |
| Ross Leonard S | See Remarks | 03/19/2019 | 4,285 |
| Ross Leonard S | See Remarks | 12/22/2018 | 30,561 |
| ROGERS MICHAEL W | Director | 11/15/2018 | 113,000 |
| Ross Leonard S | See Remarks | 10/12/2018 | 9,512 |
| Paggiarino Dario A. | Chief Medical Officer | 10/12/2018 | 7,930 |
| EW Healthcare Partners, L.P. | 10% Owner | 06/25/2018 | 825,089 |
| EW Healthcare Partners, L.P. | 10% Owner | 06/25/2018 | 20,507,955 |
| Ross Leonard S | See Remarks | 06/27/2018 | 3,541 |
| Paggiarino Dario A. | Chief Medical Officer | 06/27/2018 | 5,478 |
| Mazzo David J | Director | 04/20/2018 | 135,600 |
| EW Healthcare Partners, L.P. | 10% Owner | 03/28/2018 | 366,149 |
| EW Healthcare Partners, L.P. | 10% Owner | 03/28/2018 | 9,100,807 |
| Lurker Nancy | President and CEO | 06/14/2017 | 99,962 |
| Ashton Paul | President & CEO | 03/18/2016 | 11,300 |
| Ross Leonard S | Vice President, Finance | 01/04/2016 | 9,050 |
| Ross Leonard S | Vice President, Finance | 01/04/2016 | 23,500 |
| Ross Leonard S | Vice President, Finance | 12/22/2015 | 61,449 |
| Ross Leonard S | Vice President, Finance | 12/22/2015 | 182,990 |
| Ashton Paul | President & CEO | 12/22/2015 | 135,600 |
| Ashton Paul | President & CEO | 12/22/2015 | 646,800 |
| Ross Leonard S | Vice President, Finance | 12/01/2015 | 1,900 |
| Ross Leonard S | Vice President, Finance | 12/01/2015 | 4,263 |
| Ross Leonard S | Vice President, Finance | 08/03/2015 | 9,050 |
| Ross Leonard S | Vice President, Finance | 08/03/2015 | 20,250 |
| Ashton Paul | President & CEO | 10/01/2014 | 11,300 |
| Ashton Paul | President & CEO | 10/01/2014 | 42,700 |
| Ashton Paul | President & CEO | 09/02/2014 | 11,300 |
| Ashton Paul | President & CEO | 09/02/2014 | 47,800 |
| Ashton Paul | President & CEO | 08/01/2014 | 11,300 |
| Ashton Paul | President & CEO | 08/01/2014 | 43,700 |
| Ashton Paul | President & CEO | 07/01/2014 | 11,300 |
| Ashton Paul | President & CEO | 07/01/2014 | 43,200 |
| Ashton Paul | President & CEO | 06/19/2014 | 3,468 |
| Ashton Paul | President & CEO | 06/18/2014 | 4,442 |
| Ashton Paul | President & CEO | 06/18/2014 | 15,724 |
| Ashton Paul | President & CEO | 06/19/2014 | 12,276 |
| Freedman Lori | VP Corp. Affairs, GC and Sec | 06/17/2014 | 8,080 |
| Freedman Lori | VP Corp. Affairs, GC and Sec | 06/16/2014 | 6,219 |
| Freedman Lori | VP Corp. Affairs, GC and Sec | 06/16/2014 | 13,778 |
| Freedman Lori | VP Corp. Affairs, GC and Sec | 06/17/2014 | 17,856 |
| Ashton Paul | President & CEO | 06/16/2014 | 3,616 |
| Ashton Paul | President & CEO | 06/17/2014 | 5,085 |
| Ashton Paul | President & CEO | 06/17/2014 | 18,000 |
| Ashton Paul | President & CEO | 06/16/2014 | 12,832 |
| Ashton Paul | President & CEO | 06/13/2014 | 2,486 |
| Ashton Paul | President & CEO | 06/12/2014 | 10,848 |
| Ashton Paul | President & CEO | 06/13/2014 | 8,822 |
| Ashton Paul | President & CEO | 06/12/2014 | 38,592 |
| Freedman Lori | VP Corp. Affairs, GC and Sec | 06/13/2014 | 3,801 |
| Freedman Lori | VP Corp. Affairs, GC and Sec | 06/12/2014 | 17,376 |
| Freedman Lori | VP Corp. Affairs, GC and Sec | 06/13/2014 | 8,421 |
| Freedman Lori | VP Corp. Affairs, GC and Sec | 06/12/2014 | 38,592 |
| Freedman Lori | VP Corp. Affairs, GC and Sec | 05/05/2014 | 6,335 |
| Freedman Lori | VP Corp. Affairs, GC and Sec | 05/05/2014 | 14,035 |
| Ashton Paul | President & CEO | 05/05/2014 | 3,955 |
| Ashton Paul | President & CEO | 05/05/2014 | 14,035 |
| Hopper Paul | Director | 10/01/2012 | 16,750 |
| Hopper Paul | Director | 10/01/2012 | 16,150 |
Load More Insider Transactions
FUNDS WITH A POSITION IN EYEPOINT PHARMACEUTICALS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,756,299 | 0.19% | 6.49% | Other |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,763,888 | 2.89% | -7.22% | Growth At A Reasonable Price |
| BLACKROCK INC. | 2,787,359 | 0.00134% | 28.49% | Other |
| RA CAPITAL MANAGEMENT, L.P. | 938,591 | 0.25% | New | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 832,637 | 0.00159% | 22.01% | Other |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 579,594 | 0.21% | New | Other |
| CANDRIAM S.C.A. | 383,000 | 0.05% | 173.57% | Other |
| D. E. SHAW & CO., INC. | 100,960 | 0.00204% | Exited | Other |
| RENAISSANCE TECHNOLOGIES LLC | 71,900 | 0.00234% | New | Other |
| AQR CAPITAL MANAGEMENT LLC | 59,076 | 0.00208% | 143.43% | Other |
| GOTHAM ASSET MANAGEMENT, LLC | 32,052 | 0.01% | 143.57% | Other |
| TUDOR INVESTMENT CORP ET AL | 22,044 | 0.0029% | New | Event Driven, Other |
CHANGE IN SHARES OUTSTANDING FOR EYEPOINT PHARMACEUTICALS INC
STOCK BUYBACKS FOR EYEPOINT PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
03/31/2023
41.15%
4Q
12/31/2022
41.66%
5Q
09/30/2022
41.71%
6Q
06/30/2022
41.77%
7Q
03/31/2022
42.04%
8Q
12/31/2021
61.59%
9Q
09/30/2021
83.94%
10Q
06/30/2021
84.08%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR EYEPOINT PHARMACEUTICALS INC
LOADING...